HOOKIPA announces positive preliminary Phase 1 immunogenicity data for its immunotherapy candidates to treat advanced HPV16+ cancers Nasdaq:HOOK

Press/Media

Period10 Apr 2021

Media coverage

1

Media coverage

  • TitleHOOKIPA announces positive preliminary Phase 1 immunogenicity data for its immunotherapy candidates to treat advanced HPV16+ cancers Nasdaq:HOOK
    Media name/outletMENAFN -Press Releases (English)
    Country/TerritoryJordan
    Date10/04/21
    PersonsDmitriy Zamarin
View all 1
View less